The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d

Research output: Contribution to journalComment/debate

6 Scopus citations
Original languageEnglish
Pages (from-to)JC75
JournalAnnals of Internal Medicine
Volume174
Issue number7
DOIs
StatePublished - 1 Jul 2021

Cite this